Related references
Note: Only part of the references are listed.Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community
Marcus D. Ruopp et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Yaniv Lustig et al.
EUROSURVEILLANCE (2021)
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri et al.
LANCET (2021)
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting
Stefan Roest et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization
Varda Shalev et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)